C41H43N3O9 Cytidine, N-benzoyl-5′-O-[bis (4-methoxyphenyl) phenylmethyl]-2′-O- (2-methoxyethyl) -5-methyl- (9CI, ACI) H335, H319, H315

SILES Canonical O=C1N=C(NC(=O)C=2C=CC=CC2)C(=CN1C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6 = CC=C(OC)C=C6)C(O)C3OCCOC)C
ISOMERIC SMILES
C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C(=O)N=C(NC(=O)C3=CC=CC =C3)C(C)=C2)(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5) C6=CC=CC=C6
InChi
InChi=1S/C41H43N3O9/c1-27-25-44(40(47)43-37(27)42-38(46)28-11 -7-5-8-12-28)39-36(51-24-23-48-2)35(45)34(53-39)26-52-41(29-13)
-9-6-10-14-29,30-15-19-32(49-3)20-16-30)31-17-21-33(50-4)22-18- 31/h5-22,25,34-36,39,45H,23-24,26H2,1-4H3,(H,42,43,46,47)/t34-,3 5-,36-,39- / m1 / s1
InChi Key
BYSCLUAIKFEFAH-LZURGKRNSA-N
23 Awọn orukọ miiran fun nkan yii
N-Benzoyl-5'-O-[bis (4-methoxyphenyl) phenylmethyl] -2'-O- (2-methoxyethyl) -5-methylcytidine (ACI); 10: PN: WO03084478 EWE: 57 so RNA; 12: PN: US20030170636 EWE: 17 so R NA; 13: PN: US20030212017 EWE: 19 so R NA; 14: PN: US20030

211606 EWE: 19 so R NA; 15: PN: US20040005569 EWE: 22 so R NA; 16: PN: US20040006030 EWE: 22 so R NA; 16: PN: US20040014048 EWE: 20 so R NA; 17: PN: US20030171313 EWE: 9 so R NA; 17: PN: US20040005565 EWE: 17- 22 ti o ni ẹtọ RNA; 17: PN: US20040005570 EWE: 20 so R NA; 17: PN: US20040014047 EWE: 20 so R NA; 17: PN: US20040 014050 EWE: 20 so R NA; 18: PN: US20030198965 EWE: 19 so R NA; 18: PN: US20040014699 EWE: 20 so R NA; 19: PN: US20040006029 EWE: 23 so R NA; 19: PN: WO03106645 EWE: 71 so R NA; 59: PN: US20030166592 OJU: 15 beere RNA; 6: PN: WO2005006958 OJU: 62 beere R NA; 83: PN: US20040171566 EWE: 18 so R NA; 8: PN: WO2005007825
EWE: 62 so R NA; 90: PN: US20040005707 EWE: 20 so R NA; N4-Benzoyl-2′-O-methoxyethyl-5′-O-dimethoxytrityl-5-
methylcytidine